PALB2 Gene Mutation
13 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells (NCT04150042) | General Oncology, Inc. | 2021-01-13 |
| Olaparib In Metastatic Breast Cancer (NCT03344965) | Beth Israel Deaconess Medical Center | 2018-04-01 |
| Stand up to Cancer: MAGENTA (Making Genetic Testing Accessible) (NCT02993068) | M.D. Anderson Cancer Center | 2017-04-18 |
| Lung-MAP: Talazoparib in Treating Patients With HRRD Positive Recurrent Stage IV Squamous Cell Lung Cancer (NCT03377556) | SWOG Cancer Research Network | 2017-03-03 |
| The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a DNA Repair Gene Mutation. (NCT05097274) | Institute of Cancer Research, United Kingdom | 2015-10-15 |
| Talazoparib in Treating Patients With Recurrent, Refractory, Advanced, or Metastatic Cancers and Alterations in the BRCA Genes (NCT02286687) | M.D. Anderson Cancer Center | 2014-12-22 |
Track PALB2 Gene Mutation automatically
Every clearance here is in the API, with alerts when new ones post.